tyrosine kinase inhibitor - Globe Thesis

Keyword [tyrosine kinase inhibitor] Result: 61 - 80 \| Page: 4 of 10
61.	Expression Of EGFR In Tongue Squamous Cell Carcinoma And Effects Of EGFR-TKI On Tca8113in Vitro
62.	Four Yuan Heterocyclic Small Molecule Modification, Synthesis And The Treatment Of Egfr Tyrosine Kinase Inhibitor Modification Research
63.	Efficacy And Prognosis Of The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor On52Cases Of Advanced Non-small-cell Lung Cancer
64.	An Exploratory Study On Screening Of Spcific Peptides In Patients With NSCLC And EGFR-TKI Efficacy Related Peptides By Serum Mass Spectrum
65.	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor As Maintenance Therapy For Advanced Non-Small-Cell Lung Cancer: A Meta-analysis Of Randomized Controlled Trials
66.	Sequential TKI In Combination With Chemotherapy In The Treatment Of Advanced Non-small Cell Lung Cancer With Acquired Tyrosine Kinase Inhibitor Resistance
67.	Mutation Analysis Of ECFR&K-RAS By Realtime Polymerase Chain Reaction Using Scorpion Amplification Refractory Mutation System And Relationship Between EGFR&K-RAS Mutation And Response To Tyrosine Kinase Inhibitor Treatment In Chinese Patients With Non-sma
68.	Retreatment With Tyrosine Kinase Inhibitor After Resistance Of Gefitinib Treatment In Advanced Non-small Cell Lung Cancer
69.	Multi-targeted Tyrosine Kinase Inhibitor ZD6474Through The NF-KappaB Pathway Inhibition Of IL-8Expression In Ovarian Cancer
70.	The Effect And Mechanism Of Sunitinib On Proliferation And Apoptosis In HaCat Cells Induced By EGF
71.	Design And Synthesis Of Novel Protein Tyrosine Kinase Inhibitor
72.	Research Progresses Of Resistance Mechanisms And Therapeutic Strategies For Patients With Non-small Cell Lung Cancer After Acquired Resistance To EGFR-TKIs
73.	Analysis Of Clinical Prognostic Determinants Of319Patients Of Advanced Lung Adenocarcinoma
74.	The Effects Of Protein Kinase C Inhibitors On Cardiotoxicity Induced By Imatinib And Sunitinib
75.	Comparison Of The Efficacy Of TKI In Patients Diagnosed With Advanced Lung Adenocarcinoma, Harboring Different EGFR, KRAS Mutation Status
76.	RCTs Tyrosine Kinase Inhibitor Medical Treatment Related To The Rash Of Epidermal Growth Factor Receptor
77.	Cytotoxicity Effects And Mechanisms Studies Of Vγ9Vδ2T Cells On Human Acute Myeloid Leukemia Cells
78.	Mechanisms And Strategies On Drug Resistance Of EGFR-mutant Non-small Cell Lung Cancer
79.	Individualized Therapy Of Advanced Non-small Cell Lung Cancer With Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
80.	Mutant-enriched PCR Combined With Pyrosequencing To Detect KRAS Mutations In Cancer Tissue And Matched Blood In NSCLC Patients
<<First <Prev Next> Last>> Jump to